MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-19-0024898
Market Cap
₹27.13 Cr
ADESHWAR · BSE
Share Price
₹17.00
-9.57% today
Revenue
₹56.10 Cr
FY 2025-26 · -33.0% YoY
EBITDA
₹2.76 Cr
Margin 4.9%
Net Profit
₹1.25 Cr
FY 2025-26 · -36.6% YoY
P/E (TTM)
33.1x
P/B 1.7x
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹14.43 Cr
Issued & subscribed
About Adeshwar Meditex Limited
Data last updated:
Adeshwar Meditex Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 02 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L52390MH2007PLC169544. Its GSTIN is 27AAGCA2560A1Z7 (Maharashtra). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 543309.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹14.43 Cr. It was formerly known as Adeshwar Meditex Private Limited. It is led by directors including Ashalata Baburao Raut (Managing Director) and Krishnojirao Nagaraja Rao (Whole-Time Director).
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹56.1 Cr, a decline of 33% compared to the previous year. For the same year it recorded a net profit of ₹1.25 Cr (net margin 2.2%) and EBITDA of ₹2.76 Cr (EBITDA margin 4.9%). The net worth stands at ₹38.28 Cr (up 3.6% YoY). Total assets are valued at ₹44.73 Cr (down 10.3% YoY).
The company has about 16 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Adeshwar Meditex. As per MCA filings, the company has open charges of ₹42.44 Cr and satisfied charges of ₹11.75 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 2 cases are pending. The company has 18 deals on record (8 market trades, 4 funding rounds, 3 rights issues), with disclosed funding of ₹1.7 Cr; the latest was in August 2023. Its 4 peer companies in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Angstrom Biotech Private Limited with revenue of ₹86.9 Cr.
Adeshwar Meditex Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0024898). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website adeshwarmedi.com.
Company details
CIN L52390MH2007PLC169544
Registration Number 169544
Incorporation Date 02 April 2007
ROC Mumbai
Listing Status Listed - Listed on BSE (543309)
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0024898
CIN history
Adeshwar Meditex has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L52390MH2007PLC169544, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L52390MH2007PLC169544 | Current |
| U52390MH2007PTC169544 | Previous |
| U52390MH2007PLC169544 | Previous |
Key People
Ashalata Baburao Raut Managing Director Krishnojirao Nagaraja Rao Whole-Time Director Nagaraja Rao Abhinandan Whole-Time Director Recognitions & Rankings of Adeshwar Meditex
Contact details
Adeshwar Meditex Limited's registered office is in Mumbai, Maharashtra. Its website is adeshwarmedi.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGala 111 Lok Centre, Marol Maroshi Road Andheri East, Mumbai, Maharashtra, India – 400059
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Adeshwar Meditex Limited, buy the company report.
Comprehensive company report
Adeshwar Meditex Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Adeshwar Meditex operates one associated brand: Adeshwar Meditex. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Sterile surgical wound dressings and medical disposables are manufactured. | adeshwarmeditex.com |
Business activity
The main business activity of Adeshwar Meditex is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Adeshwar Meditex Limited, buy the company report.
Financials of Adeshwar Meditex Limited
FY 2025-26 filings availableAdeshwar Meditex Limited reported revenue of ₹56.1 Cr (down 33% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹56.10 Cr
-33.0% YoY
EBITDA
₹2.76 Cr
-37.6% YoY
Profit After Tax
₹1.25 Cr
-36.5% YoY
Net Worth
₹38.28 Cr
+3.6% YoY
Total Assets
₹44.73 Cr
-10.3% YoY
Total Debt
₹6.00 Cr
-51.8% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 56.10 | 83.71 | 79.85 | 82.36 | 64.76 | 65.97 | 56.12 |
| Revenue growth | -33.0% | +4.8% | -3.1% | +27.2% | -1.8% | +17.6% | - |
| EBITDA | 2.76 | 4.42 | 5.18 | 5.22 | 3.37 | 4.59 | 5.49 |
| EBITDA margin | +4.9% | +5.3% | +6.5% | +6.3% | +5.2% | +7.0% | +9.8% |
| Profit before tax | 1.82 | 2.79 | 2.78 | 2.91 | 1.19 | 2.32 | 2.91 |
| Net profit | 1.25 | 1.97 | 2.00 | 2.08 | 0.79 | 1.75 | 2.12 |
| Net profit margin | +2.2% | +2.4% | +2.5% | +2.5% | +1.2% | +2.7% | +3.8% |
| EPS (₹) | 0.88 | 1.43 | 1.39 | 1.44 | 0.55 | 1.59 | 4.02 |
| Balance sheet | |||||||
| Total assets | 44.73 | 49.84 | 49.13 | 49.76 | 50.41 | 43.56 | 40.79 |
| Net worth | 38.28 | 36.96 | 34.91 | 32.91 | 30.95 | 20.58 | 18.91 |
| Total debt | 6.00 | 12.45 | 13.89 | 16.43 | 18.99 | 22.45 | 21.32 |
| Cash & bank | 0.01 | 2.04 | 1.16 | 1.90 | 1.92 | 1.07 | 1.73 |
| Net working capital | 38.98 | 43.70 | 42.22 | 42.33 | 42.93 | 38.32 | 36.00 |
| Cash flow | |||||||
| Cash from operations | 4.97 | 3.80 | 3.84 | 5.77 | (2.44) | 3.15 | (0.99) |
| Cash from investing | 0.10 | (0.26) | (0.22) | (1.16) | (1.16) | (0.71) | 1.58 |
| Cash from financing | (7.09) | (2.66) | (4.36) | (4.63) | 4.44 | (3.11) | (0.07) |
| Particulars | Mar 2021 | Dec 2020 |
|---|---|---|
| Revenue | 14.18 | 15.26 |
| Other income | (0.03) | 0.21 |
| Total expenses | 13.11 | 13.36 |
| EBITDA | 1.07 | 1.90 |
| EBITDA margin | +7.5% | +12.5% |
| Depreciation | 0.09 | 0.09 |
| Interest | 0.54 | 0.56 |
| Profit before tax | 0.41 | 1.46 |
| Tax | 0.12 | 0.40 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 08 Nov 2026
| Particulars | Mar 2021 | Dec 2020 |
|---|---|---|
| Revenue | 14.18 | 15.26 |
| Other income | (0.03) | 0.21 |
| Total expenses | 13.11 | 13.36 |
| EBITDA | 1.07 | 1.90 |
| EBITDA margin | +7.5% | +12.5% |
| Depreciation | 0.09 | 0.09 |
| Interest | 0.54 | 0.56 |
| Profit before tax | 0.41 | 1.46 |
| Tax | 0.12 | 0.40 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 56.10 | 83.71 | 79.85 | 82.36 | 64.76 | 65.97 | 56.12 |
| Revenue growth | -33.0% | +4.8% | -3.1% | +27.2% | -1.8% | +17.6% | - |
| Other income | 0.10 | 0.26 | 0.13 | 0.31 | 0.23 | 0.27 | 0.28 |
| Total expenses | 53.34 | 79.29 | 74.67 | 77.14 | 61.39 | 61.38 | 50.63 |
| Employee cost | 0.00 | 1.41 | 1.16 | 1.33 | 1.33 | 1.51 | 1.17 |
| EBITDA | 2.76 | 4.42 | 5.18 | 5.22 | 3.37 | 4.59 | 5.49 |
| EBITDA margin | +4.9% | +5.3% | +6.5% | +6.3% | +5.2% | +7.0% | +9.8% |
| Depreciation | 0.43 | 0.50 | 0.60 | 0.53 | 0.38 | 0.35 | 0.34 |
| Interest | 0.61 | 1.39 | 1.93 | 2.09 | 2.03 | 2.19 | 2.52 |
| Profit before tax | 1.82 | 2.79 | 2.78 | 2.91 | 1.19 | 2.32 | 2.91 |
| Tax | 0.57 | 0.73 | 0.78 | 0.83 | 0.40 | 0.67 | 0.79 |
| Net profit | 1.25 | 1.97 | 2.00 | 2.08 | 0.79 | 1.75 | 2.12 |
| Net profit margin | +2.2% | +2.4% | +2.5% | +2.5% | +1.2% | +2.7% | +3.8% |
| EPS (₹) | 0.88 | 1.43 | 1.39 | 1.44 | 0.55 | 1.59 | 4.02 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 14.43 | 14.43 | 14.43 | 14.43 | 14.43 | 10.53 | 5.27 |
| Reserves & surplus | 23.85 | 22.53 | 20.48 | 18.48 | 16.52 | 10.05 | 13.64 |
| Shareholders' funds (net worth) | 38.28 | 36.96 | 34.91 | 32.91 | 30.95 | 20.58 | 18.91 |
| Secured loans | 4.35 | 10.82 | 13.89 | 16.43 | 17.17 | 17.20 | 15.19 |
| Unsecured loans | 1.65 | 1.63 | 0.00 | 0.00 | 1.82 | 5.25 | 6.13 |
| Total debt | 6.00 | 12.45 | 13.89 | 16.43 | 18.99 | 22.45 | 21.32 |
| Total liabilities | 44.73 | 49.84 | 49.13 | 49.76 | 50.41 | 43.56 | 40.79 |
| Assets | |||||||
| Gross block | 10.09 | 10.01 | 10.16 | 9.73 | 8.51 | 7.35 | 7.03 |
| Net block | 2.61 | 2.96 | 3.53 | 3.70 | 3.03 | 2.24 | 2.29 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.10 | 0.10 | 0.10 | 0.08 | 0.08 |
| Inventories | 20.50 | 25.82 | 26.53 | 24.32 | 25.30 | 26.11 | 14.49 |
| Sundry debtors | 20.82 | 34.98 | 25.27 | 27.93 | 32.48 | 27.26 | 27.87 |
| Cash & bank balances | 0.01 | 2.04 | 1.16 | 1.90 | 1.92 | 1.07 | 1.73 |
| Loans & advances | 3.14 | 3.21 | 4.16 | 5.42 | 5.40 | 2.62 | 5.92 |
| Total current assets | 44.47 | 66.05 | 57.12 | 59.57 | 65.10 | 57.06 | 50.01 |
| Total current liabilities | 5.49 | 22.35 | 14.90 | 17.24 | 22.17 | 18.74 | 14.01 |
| Net working capital | 38.98 | 43.70 | 42.22 | 42.33 | 42.93 | 38.32 | 36.00 |
| Total assets | 44.73 | 49.84 | 49.13 | 49.76 | 50.41 | 43.56 | 40.79 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 2.04 | 1.16 | 1.90 | 1.92 | 1.07 | 1.73 | 1.20 |
| Net cash from operating activities | 4.97 | 3.80 | 3.84 | 5.77 | (2.44) | 3.15 | (0.99) |
| Net cash from investing activities | 0.10 | (0.26) | (0.22) | (1.16) | (1.16) | (0.71) | 1.58 |
| Net cash from financing activities | (7.09) | (2.66) | (4.36) | (4.63) | 4.44 | (3.11) | (0.07) |
| Net change in cash | (2.02) | 0.88 | (0.75) | (0.02) | 0.85 | (0.66) | 0.53 |
| Closing cash | 0.01 | 2.04 | 1.16 | 1.90 | 1.92 | 1.07 | 1.73 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -33.0% | +4.8% | -3.1% | +27.2% | -1.8% | +17.6% | - |
| EBITDA growth | -37.6% | -14.7% | -0.8% | +54.9% | -26.6% | -16.4% | - |
| PBT growth | -34.8% | +0.4% | -4.5% | +144.5% | -48.7% | -20.3% | -7.6% |
| Net income growth | -36.6% | -1.5% | -3.9% | +163.3% | -54.9% | -17.5% | - |
| Revenue CAGR (3Y) | -12.0% | +8.9% | +6.6% | +13.6% | +7.0% | +4.0% | - |
| EBITDA CAGR (3Y) | -19.1% | +9.5% | +4.1% | -1.7% | -15.0% | -6.6% | - |
| Profitability & leverage | |||||||
| Net income margin | +2.2% | +2.5% | +2.5% | +2.5% | +1.2% | +2.5% | +3.8% |
| Return on capital employed | - | +8.5% | +9.6% | +10.0% | +6.9% | +10.7% | +14.1% |
| Return on net worth | - | +5.8% | +5.9% | +6.5% | +3.1% | +8.5% | +12.2% |
| Debt / equity | - | 0.37 | 0.45 | 0.55 | 0.80 | 1.11 | 1.19 |
| Long-term debt / equity | - | 0.04 | 0.05 | 0.10 | 0.18 | 0.29 | 0.28 |
| Interest cover | 26.18 | 35.46 | 42.14 | 44.56 | 67.89 | 51.65 | 48.93 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 8.30 | 8.03 | 9.03 | 8.17 | 9.18 | 8.09 |
| Inventory turnover | - | 3.20 | 3.14 | 3.32 | 2.52 | 3.25 | 4.01 |
| Debtors turnover | - | 2.78 | 3.00 | 2.73 | 2.17 | 2.39 | 2.37 |
| EPS (₹) | 0.88 | 1.43 | 1.39 | 1.44 | 0.55 | 1.59 | 4.02 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 25.61 | 24.19 | 22.81 | 21.45 | 19.54 | 35.90 |
To see the full year-wise statements and ratios of Adeshwar Meditex Limited, buy the company report.
Board of directors of Adeshwar Meditex Limited
Adeshwar Meditex has 6 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashalata Baburao Raut Also directs: Moksha Biosurgicals Private Limited | Managing Director | 21 May 2007 | 19 Years 5 Months | Current |
| Krishnojirao Nagaraja Rao Also directs: K.N. Manasa Enterprises LLP | Whole-Time Director | 24 Mar 2017 | 9 Years 7 Months | Current |
| Shailesh Vinayak Rajpure | Director | 27 Feb 2023 | 3 Years 8 Months | Current |
| Nagaraja Rao Abhinandan | Whole-Time Director | 27 Aug 2024 | 2 Years 2 Months | Current |
| Raghupathy K Bhat | Director | 20 Dec 2025 | 0 Years 10 Months | Current |
| Bhagyalaxmi Kavital | Director | 21 May 2026 | 0 Years 5 Months | Current |
Peer comparison
Adeshwar Meditex Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Angstrom Biotech Private Limited | ₹86.9 Cr (FY 2022) | -2.0% | Vadodara, Gujarat, India | |||
| Sunil Healthcare Limited | ₹84.76 Cr (FY 2025) | -11.0% | New Delhi, Delhi, India | |||
| Beacon Diagnostics Pvt Ltd | ₹82.21 Cr (FY 2025) | -1.0% | Navsari, Gujarat, India | |||
| Erawat Pharma Limited | ₹78.37 Cr (FY 2025) | 14.0% | Indore, Madhya Pradesh, India | |||
| Adeshwar Meditex Limitedthis company | ₹56.1 Cr (FY 2026) | ₹1.25 Cr | 2.2% | -33.0% | 16 | Mumbai, Maharashtra, India |
To see the full peer comparison of Adeshwar Meditex Limited, buy the company report.
Auditor
Adeshwar Meditex Limited is audited by J N Gupta & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J N Gupta & Co. | FY 2023 | 006569C |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 57.70%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 42.30%.
Sep 2026
QUARTER
57.70% Promoters
42.30% Retail & Others
Promoter holding - history
Now 57.70% · Sep 2026High 57.70% · Sep 2026Low 57.60% · Dec 2025
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 57.70% | 57.60% | 57.60% | 57.60% |
| Public | 42.30% | 42.40% | 42.40% | 42.40% |
Charges & borrowings
Open charges
₹42.44 Cr
Satisfied charges
₹11.75 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Dec 2021 | 100554029 | Others | ₹1.14 Cr | Open | |
| 26 Jul 2021 | 100468143 | Sidbi | ₹2 Cr | Open | |
| 06 Aug 2020 | 100356999 | Sidbi | ₹50 Lakh | Open | |
| 17 May 2016 | 100032296 | Others | ₹13.31 Cr | Open | |
| 24 Oct 2007 | 10086021 | Others | ₹13.31 Cr | Open |
To see the full charge records of Adeshwar Meditex Limited, buy the company report.
Total charge records: 15 View all charges
Deals & funding
Adeshwar Meditex Limited has 18 deals on record (8 market trades, 4 funding rounds, 3 rights issues), with disclosed funding of ₹1.7 Cr; the latest was in August 2023.
Total deals
18
Market trades
8
Funding rounds
4
Rights issues
3
Secondary share transfers
2
Disclosed funding
₹1.7 Cr
Deals on record (5 of 18)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2023 | Market trade | ₹19.1 Lakh | Buyer: Spark Finance Seller: Spark Finance |
| Apr 2023 | Market trade | ₹52.6 Lakh | Buyer: an individual Seller: Overskud Multi Asset Management Private Limited , Aryaman Capital Markets Limited |
| Jul 2021 | Market trade | ₹39.2 Lakh | Buyer: Amish Rasik Mehta Huf |
| Jul 2021 | Market trade | ₹60.2 Lakh | Buyer: Stellar Growth Advisors Private Limited , Aryaman Capital Markets Limited Seller: Aryaman Capital Markets Limited |
| Jul 2021 | Market trade | ₹48.3 Lakh | Buyer: Amish Rasik Mehta Huf |
To see the full deal history of Adeshwar Meditex Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Adeshwar Meditex Limited has 5 court cases on record: 3 filed by Adeshwar Meditex, 2 filed against it. 2 cases are pending and 3 are disposed.
Total cases
5
Filed by the company
3
Filed against the company
2
Pending
2
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 2 |
| High courts | 2 | 0 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Aurangabad, Maharashtra | Criminal miscellaneous application | Filed against the company by The State of Maharashtra | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed by the company against Global Konkan Enterprise | Pending |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against The State of Maharashtra, Department of Home (Excise) and Anr. | Disposed |
| District court, Aurangabad, Maharashtra | Criminal miscellaneous application | Filed against the company by State of Maharashtra at the Instance of Rajgopal Mulchand Bajaj, Drug Inspector | Disposed |
| Bombay High Court | Writ petition | Filed by the company against Directorate of Health Services and Ors. | Disposed |
To see the full case history of Adeshwar Meditex Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adeshwar Meditex Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Adeshwar Meditex Limited has a workforce of 16 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
16
Active EPFO establishments
1
Employee growth
6.67%
GST
Adeshwar Meditex has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCA2560A1Z7 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Adeshwar Meditex Limited, buy the company report.
Recent activity
Adeshwar Meditex Limited has 31 board changes on record since 2007: 19 appointments and 12 cessations. The latest: Bhagyalaxmi Kavital was appointed as Director on 21 May 2026.
Appointed
Bhagyalaxmi Kavital was appointed as Director.
Filing
Adeshwar Meditex Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
Appointed
Raghupathy K Bhat was appointed as Director.
Ceased
Benegal Parameshwara Udpa ceased to be Director.
AGM
Adeshwar Meditex Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Charges
A charge registered on 09 Sep 2020 via Charge ID 100402556 with Others was fully satisfied on 07 Jan 2025.
Charges
A charge registered on 29 Jun 2020 via Charge ID 100398307 with Others was fully satisfied on 07 Jan 2025.
Charges
A charge registered on 28 Mar 2018 via Charge ID 100167969 with Others was fully satisfied on 07 Jan 2025.
Charges
A charge registered on 17 May 2016 via Charge ID 100032289 with Others was fully satisfied on 07 Jan 2025.
Charges
A charge registered on 28 Aug 2015 via Charge ID 10592457 with Union Bank Of India was fully satisfied on 07 Jan 2025.
Charges
A charge registered on 03 Dec 2014 via Charge ID 10545286 with Union Bank Of India was fully satisfied on 07 Jan 2025.
Charges
A charge registered on 06 Nov 2007 via Charge ID 10073368 with Union Bank Of India was fully satisfied on 07 Jan 2025.
51 earlier events are in the company report.
News
Frequently asked questions
Adeshwar Meditex is an active public limited company based in Mumbai, Maharashtra, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 02 April 2007 (19+ years old) and is registered under CIN L52390MH2007PLC169544. Listed on BSE: 543309.
Adeshwar Meditex reported revenue of ₹56.1 Cr for FY 2025-26 (down 33% YoY) based on standalone financials.
Adeshwar Meditex has 6 current directors:
- Ashalata Baburao Raut - Managing Director
- Krishnojirao Nagaraja Rao - Whole-Time Director
- Nagaraja Rao Abhinandan - Whole-Time Director
- Shailesh Vinayak Rajpure - Director
- Raghupathy K Bhat - Director
- Bhagyalaxmi Kavital - Director
The latest financial statements of Adeshwar Meditex on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Adeshwar Meditex is 27AAGCA2560A1Z7, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Adeshwar Meditex is L52390MH2007PLC169544. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Adeshwar Meditex is a listed company as per MCA records. Its shares are listed on BSE (code: 543309).
Adeshwar Meditex has 5 court cases on record: 3 filed by the company and 2 filed against it. 2 are pending. Most are in the district courts.
Adeshwar Meditex was incorporated on 02 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
Adeshwar Meditex has 18 deals on record (8 market trades, 4 funding rounds, 3 rights issues), with disclosed funding of ₹1.7 Cr; the latest was in August 2023.
The peers of Adeshwar Meditex by revenue are Angstrom Biotech Private Limited, Sunil Healthcare Limited, Beacon Diagnostics Pvt Ltd, Erawat Pharma Limited, all in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages